Two Lots of Accusure Insulin Syringes Recalled

Accusure Insulin Syringes made by Qualitest Pharmaceuticals, Inc., have been recalled because the needles in the syringes may detach during use, deliver an improper dose of insulin, or remain stuck in the patient’s skin after injection, the Food and Drug Administration said.

The recall, announced August 21, involves separate lots of two Accusure insulin syringe products. The following products are included in the voluntary, nationwide recall:

• Accusure Insulin Syringes (1/2 cc – 31 G – Short Needle) with lot number 6JCB1 (Expiration 10/2011) and UPC number NDC 0603-7001-21

• Accusure Insulin Syringes (1 cc – 31 G –Short Needle) with lot number 7CPT1 (Expiration 03/2012) and UPC number NDC 0603-7002-21

The lot numbers and UPC codes can be found on the white paper backing of each individual syringe, the FDA recall notice states.

The syringes were distributed between January 2007 and June 2008 to retail pharmacies and wholesalers across the United States and Puerto Rico, the FDA said. When the needle is detached from the syringe during use, it can push back into the syringe, become stuck in the vial of insulin, or remain stuck in the user’s skin, officials warned.

Consumers who have the recalled Accusure Insulin Syringes should immediately stop using them and contact Qualitest at 1-800-444-4011 for product replacement instructions, the FDA said.

No related posts.